Skip to main content
. Author manuscript; available in PMC: 2016 Oct 1.
Published in final edited form as: Ophthalmology. 2015 Aug 20;122(10):1967–1975. doi: 10.1016/j.ophtha.2015.06.042

Figure 4.

Figure 4

Proportion of uveitic eyes with uveitis activity for those assigned to implant (dotted line) and systemic (solid line) therapy during the first 54 months of follow-up in the Multicenter Uveitis Steroid Treatment (MUST) Trial and Follow-up Study.